MedTrace Logo

Clinical Trial to Examine Effectiveness of a Human Allograft for Treatment of DFU and VLU

NCT03999281 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 188

Last updated 2019-06-28

No results posted yet for this study

Summary

Retrospective clinical study of 188 patients to examine effectiveness of human cryopreserved allograft in the treatment of diabetic foot ulcers and venous leg ulcers

Conditions

  • Determine Effectiveness of Theraskin in the Treatment of DFU and VLU

Interventions

OTHER

Human Allograft (Theraskin)

Biologically active cryopreserved human skin allograft (Theraskin) was used on both cohorts, both diabetic foot ulcer and venous leg ulcer.

Sponsors & Collaborators

  • Solsys Medical LLC

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-20
Primary Completion
2009-09-20
Completion
2009-09-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03999281 on ClinicalTrials.gov